These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 23898082)
1. Effects of bisphosphonates in combination with ionizing radiation and antioxidants on the growth of prostate and melanoma cells lines. Alcaraz M; Olivares A; Achel DG; Alcaraz-Saura M Anticancer Res; 2013 Aug; 33(8):3217-24. PubMed ID: 23898082 [TBL] [Abstract][Full Text] [Related]
2. [Decrease in toxicity and therapeutic effect of zoledronic acid in combination therapy with different antioxidant extracts]. Lopez-Morata JA; Olivares A; Alcaraz M Rev Esp Geriatr Gerontol; 2016; 51(6):329-334. PubMed ID: 26948964 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitizing effect of rosmarinic acid in metastatic melanoma B16F10 cells. Alcaraz M; Alcaraz-Saura M; Achel DG; Olivares A; López-Morata JA; Castillo J Anticancer Res; 2014 Apr; 34(4):1913-21. PubMed ID: 24692726 [TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid and radiation: toxicity, synergy or radiosensitization? Alcaraz M; Olivares A; Armero D; Alcaraz-Saura M; Achel D Clin Transl Oncol; 2013 Apr; 15(4):300-6. PubMed ID: 23443898 [TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676 [TBL] [Abstract][Full Text] [Related]
6. In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells. Ural AU; Avcu F; Candir M; Guden M; Ozcan MA Breast Cancer Res; 2006; 8(4):R52. PubMed ID: 16925824 [TBL] [Abstract][Full Text] [Related]
7. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay. Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973 [TBL] [Abstract][Full Text] [Related]
8. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer. Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444 [TBL] [Abstract][Full Text] [Related]
9. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells. Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119 [TBL] [Abstract][Full Text] [Related]
10. Carnosol, radiation and melanoma: a translational possibility. Alcaraz M; Achel DG; Olivares A; Olmos E; Alcaraz-Saura M; Castillo J Clin Transl Oncol; 2013 Sep; 15(9):712-9. PubMed ID: 23359182 [TBL] [Abstract][Full Text] [Related]
11. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation. Sayeed A; Lu H; Liu Q; Deming D; Duffy A; McCue P; Dicker AP; Davis RJ; Gabrilovich D; Rodeck U; Altieri DC; Languino LR Oncotarget; 2016 Aug; 7(33):52618-52630. PubMed ID: 27438371 [TBL] [Abstract][Full Text] [Related]
14. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma. Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate treatment inhibits the growth of prostate cancer cells. Lee MV; Fong EM; Singer FR; Guenette RS Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137 [TBL] [Abstract][Full Text] [Related]
16. In vitro toxicity of bisphosphonates on human neuroblastoma cell lines. Vorotnjak M; Boos J; Lanvers-Kaminsky C Anticancer Drugs; 2004 Sep; 15(8):795-802. PubMed ID: 15494642 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer. Montague R; Hart CA; George NJ; Ramani VA; Brown MD; Clarke NW Eur Urol; 2004 Sep; 46(3):389-401; discussion 401-2. PubMed ID: 15306113 [TBL] [Abstract][Full Text] [Related]
18. Toxicity of a dental adhesive compared with ionizing radiation and zoledronic acid. Alcaraz M; Olivares A; Achel DG; García-Cruz E; Fondevilla-Soler A; Canteras-Jordana M Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e427-34. PubMed ID: 26034923 [TBL] [Abstract][Full Text] [Related]
19. Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Shukla S; MacLennan GT; Flask CA; Fu P; Mishra A; Resnick MI; Gupta S Cancer Res; 2007 Jul; 67(14):6925-35. PubMed ID: 17638904 [TBL] [Abstract][Full Text] [Related]
20. Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells. Journé F; Kheddoumi N; Chaboteaux C; Duvillier H; Laurent G; Body JJ Breast Cancer Res; 2008; 10(1):R4. PubMed ID: 18190680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]